Veeva Vault Validation Management to streamline end-to-end validation processes BARCELONA, Spain \u2014 15 Sept. 2021 \u2014<\/strong> Veeva Systems<\/a> (NYSE: VEEV) today announced Veeva Vault Validation Management<\/a>, a new application that will enable more efficient, cost-effective validation lifecycle management. Life sciences companies will be able to create and organize validation activities, manage a global library of test scripts, and execute and record validation data electronically for faster test execution and greater compliance. <\/p>\n \u201cManual validation processes are ineffective, draining resources and increasing operational cost,\u201d said Mike Jovanis, vice president of Veeva Vault Quality. \u201cVeeva Vault Validation Management will allow customers to optimize the end-to-end validation lifecycle with paperless execution for increased efficiency and audit readiness.\u201d <\/p>\n Vault Validation Management will reduce manual processes and eliminate silos for better tracking and alignment across validation activities and projects. Quality teams will be able to use suggested artifacts and templates to drive consistency, ensuring good documentation practices (GDP) and data integrity. <\/p>\n Seamless integration with Veeva Vault QualityDocs<\/a> and Veeva Vault QMS<\/a> will connect key artifacts, discrepancies, and change controls, improving transparency and data accessibility. Intuitive dashboards also display critical metrics like status and cycle times for better traceability across validation projects.<\/p>\n Vault Validation Management is part of the Veeva Vault Quality Suite<\/a>, including Vault QMS, Vault QualityDocs, Veeva Vault Training<\/a>, Veeva LearnGxP<\/a>, Veeva Vault Station Manager<\/a>, and Veeva Vault Product Surveillance<\/a> to automate and harmonize quality processes globally. Vault Quality Suite enables companies to easily manage quality in one unified solution and delivers the power and scalability needed across the life sciences value chain.<\/p>\n Vault Validation Management is planned for availability in the second half of 2022. To learn more about Vault Validation Management, visit veeva.com\/eu\/VaultValidationManagement<\/a>.<\/p>\n Attend Veeva R&D and Quality Summit Connect<\/a> on 14 October 2021 to hear more about the new offering, Merck & Co., Inc.\u2019s digital quality transformation journey, and Supernus Pharmaceuticals\u2019 organizational change management best practices for quality modernization. The online event is open to life sciences industry professionals. Register and stay up to date on program details at veeva.com\/Summit<\/a>.<\/p>\n Additional Information<\/strong> About Veeva Systems<\/strong> Forward-looking Statements<\/strong> ###<\/p>\n Contact:<\/strong><\/p>\n Deivis Mercado
for audit readiness and compliance<\/em><\/p>\n
\nConnect with Veeva on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>
\nFollow @veeva_eu on Twitter: twitter.com\/veeva_eu<\/a><\/p>\n
\nVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,100 customers, ranging from the world\u2019s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended July 31, 2021. This is available on the company\u2019s website at veeva.com<\/a> under the Investors section and on the SEC\u2019s website at sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time. <\/p>\n
\nVeeva Systems
\n925-226-8821
\ndeivis.mercado@veeva.com<\/a><\/p>\n